Mylan Pharmaceuticals Inc. v. Galderma Laboratories Inc.

Application Number	Patent Number	External Links
-	US7749532	Espacenet Google Patents

COMPLAINT filed against Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-797160.) - filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dlk) (Entered: 10/19/2010)

2010-10-18

1

Download

COMPLAINT filed against Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-797160.) - filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dlk) (Entered: 10/19/2010)

2010-10-18

2

View

COMPLAINT filed against Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-797160.) - filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dlk) (Entered: 10/19/2010)

2010-10-18

2

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dlk) (Entered: 10/19/2010)

2010-10-18

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2; (dlk) (Entered: 10/19/2010)

2010-10-18

1

View

Summons Issued as to Galderma Laboratories Inc. on 10/19/2010; Galderma Laboratories LP on 10/19/2010; Supernus Pharmaceuticals Inc. on 10/19/2010. (dzs, )

2010-10-19

1

No Actions

No Summons Issued (dlk)

2010-10-19

1

No Actions

SUMMONS Returned Executed by Mylan Pharmaceuticals Inc.. Supernus Pharmaceuticals Inc. served on 10/19/2010, answer due 11/9/2010. (Moore, David) (Entered: 10/20/2010)

2010-10-20

1

View

SUMMONS Returned Executed by Mylan Pharmaceuticals Inc.. Galderma Laboratories Inc. served on 10/19/2010, answer due 11/9/2010. (Moore, David) (Entered: 10/20/2010)

2010-10-20

1

View

SUMMONS Returned Executed by Mylan Pharmaceuticals Inc.. Galderma Laboratories LP served on 10/19/2010, answer due 11/9/2010. (Moore, David) (Entered: 10/20/2010)

2010-10-20

1

View

MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter and for Failure to State a Claim - filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Blumenfeld, Jack) (Entered: 10/26/2010)

2010-10-26

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc. identifying Corporate Parent Galderma Pharma S.A. for Galderma Laboratories Inc... (Blumenfeld, Jack) (Entered: 10/26/2010)

2010-10-26

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc. identifying Corporate Parent Galderma General LLC, Corporate Parent Galderma Limited LLC for Galderma Laboratories LP.. (Blumenfeld, Jack) (Entered: 10/26/2010)

2010-10-26

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc. identifying Corporate Parent none for Supernus Pharmaceuticals Inc... (Blumenfeld, Jack) (Entered: 10/26/2010)

2010-10-26

1

View

RESPONSE to Motion re 7 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter and for Failure to State a Claim [PLAINTIFF'S OPPOSITION TO MOTION TO DISMISS] filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Moore, David) (Entered: 10/27/2010)

2010-10-27

1

View

Case assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (bkb)

2010-10-27

1

No Actions

AFFIDAVIT of Service for Summons, Complaint and the Notice, Consent and Reference to a Magistrate Judge Forms served on Galderma Laboratories, L.P. on October 19, 2010, filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 11/02/2010)

2010-11-02

1

View

MOTION for Pro Hac Vice Appearance of Attorney Ron E. Shulman, Terry Kearney, Melissa A. Kopacz, Michael D. Nguyen, Michael A. Berta, Tung-On Kong and Lorelie P. Westin of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 11/08/2010)

2010-11-08

1

View

NOTICE of Withdrawal of Motion by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc. re 7 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter and for Failure to State a Claim (Blumenfeld, Jack) (Entered: 11/08/2010)

2010-11-08

1

View

ANSWER to 1 Complaint, for Declaratory Judgment, COUNTERCLAIM against Mylan Pharmaceuticals Inc. by Galderma Laboratories LP, Galderma Laboratories Inc., Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Noreika, Maryellen) (Entered: 11/09/2010)

2010-11-09

1

View

Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding scheduling of discovery dispute teleconference. (Moore, David) (Entered: 11/11/2010)

2010-11-11

1

View

ORAL ORDER: IT IS ORDERED that a status teleconference is scheduled for November 18, 2010 at 8:30 a.m. to address the disputes noted in Defendants' letter of November 11, 2010 (D.I. 233). Defendant's counsel shall initiate the teleconference call to 302-573-4573. Defendants may file a letter of up to 3 pages addressing the issues they wish to discuss in the teleconference no later than November 16 at 8:30 a.m. and Plaintiffs may file a responsive letter of up to 3 pages no later than November 17 at 8:30 a.m. ORDERED by Judge Leonard P. Stark on 11/12/10. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 11/12/2010)

2010-11-12

1

View

ANSWER to 15 Answer to Complaint, Counterclaim (PLAINTIFF'S ANSWER TO DEFENDANTS' COUNTERCLAIM) by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 11/12/2010)

2010-11-12

1

View

MOTION to Dismiss Based upon (MOTION TO DISMISS DEFENDANTS' "EXCEPTIONAL CASE" CLAIM PURSUANT TO FED. R. CIV. P. 12(B)(6)) - filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order)(Moore, David) (Entered: 11/12/2010)

2010-11-12

1

View

SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney Ron E. Shulman, Terry Kearney, Melissa A. Kopacz, Michael D. Nguyen, Michael A. Berta, Tung-On Kong and Lorelie P. Westin of Wilson Sonsini Goodrich & Rosati filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 11/12/2010. (rpg)

2010-11-12

1

No Actions

Letter to The Honorable Leonard P. Stark from David E. Moore regarding opening discovery dispute - re 17 Order Setting Teleconference,,. (Attachments: # 1 Exhibit A-C)(Moore, David) (Entered: 11/16/2010)

2010-11-16

1

View

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding response to Mylan's November 16, 2010 letter and in connection with the November 18, 2010 8:30 a.m. teleconference - re (235 in 1:09-cv-00184-LPS) Letter, (20 in 1:10-cv-00892-LPS) Letter. (Blumenfeld, Jack) (Entered: 11/17/2010)

2010-11-17

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 11/19/2010. (Court Reporter B. Gaffigan.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)

2010-11-19

1

No Actions

Letter to The Honorable Leonard P. Stark from David E. Moore and Jack B. Blumenfeld regarding case scheduling - re Telephone Conference. (Attachments: # 1 Exhibit A-B)(Moore, David) (Entered: 11/23/2010)

2010-11-23

1

View

ANSWERING BRIEF in Opposition re 19 MOTION to Dismiss Based upon (MOTION TO DISMISS DEFENDANTS' "EXCEPTIONAL CASE" CLAIM PURSUANT TO FED. R. CIV. P. 12(B)(6)) filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..Reply Brief due date per Local Rules is 12/13/2010. (Noreika, Maryellen) (Entered: 12/02/2010)

2010-12-02

1

View

NOTICE OF SERVICE of Mylan's First Set of Requests for Production of Documents and Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/03/2010)

2010-12-03

1

View

NOTICE OF SERVICE of Mylan's First Set of Interrogatories (Nos. 1-7) by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/03/2010)

2010-12-03

1

View

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding the Court's December 2, 2010 Order. (Blumenfeld, Jack) (Entered: 12/06/2010)

2010-12-06

1

View

Official Transcript of Telephone Conference held on November 19, 2010 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/27/2010. Redacted Transcript Deadline set for 1/6/2011. Release of Transcript Restriction set for 3/7/2011. (bpg) (Entered: 12/06/2010)

2010-12-06

1

View

Letter to The Honorable Leonard P. Stark from Richard L. Horwitz, Esquire regarding response to Galderma's letter dated December 6, 2010 - re (240 in 1:09-cv-00184-LPS, 26 in 1:10-cv-00892-LPS) Letter. (Horwitz, Richard) (Entered: 12/06/2010)

2010-12-06

1

View

NOTICE OF SERVICE of Mylan's Initial Disclosure by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/06/2010)

2010-12-06

1

View

Letter to The Honorable Leonard P. Stark from David E. Moore regarding Scheduling Order (on behalf of all parties). (Attachments: # 1 Exhibit A-B)(Moore, David) (Entered: 12/08/2010)

2010-12-08

1

View

PROPOSED ORDER Proposed Scheduling Order (on behalf of all parties) re 30 Letter by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 12/08/2010)

2010-12-08

1

View

SO ORDERED, re ( 31 in 1:10-cv-00892-LPS and 244 in 1:09-cv-00184-LPS) ) Proposed Order filed by Mylan Pharmaceuticals Inc. SCHEDULING ORDER: Trial Previously scheduled to begin on 2/14/2011 is hereby CANCELED. Scheduling Order Deadlines Reset. ( Pretrial Conference reset for 6/15/2011 10:00 AM in Courtroom 6B before Judge Leonard P. Stark. Markman Hearing set for 3/21/2011 10:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 6/6/2011. Bench Trial set for 7/5/2011 through 7/8/2011 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark ). Signed by Judge Leonard P. Stark on 12/13/2010. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg) (Entered: 12/13/2010)

2010-12-13

1

View

NOTICE OF SERVICE of Defendants' Rule 26(a)(1) Initial Disclosures by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 12/13/2010)

2010-12-13

1

View

REPLY BRIEF re 19 MOTION to Dismiss Based upon (MOTION TO DISMISS DEFENDANTS' "EXCEPTIONAL CASE" CLAIM PURSUANT TO FED. R. CIV. P. 12(B)(6)) filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 12/13/2010)

2010-12-13

1

View

NOTICE OF SERVICE of 1) Defendants' First Set of Interrogatories; and 2) Defendants' First Set of Requests for the Production of Documents and Things by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 12/16/2010)

2010-12-16

1

View

MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Melanie R. Rupert, Christine Willgoos, Jason T. Christiansen, Ryan H. Coletti and Evan D. Diamond - filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 12/20/2010)

2010-12-20

1

View

NOTICE OF SERVICE of Mylan's Second Set of Requests for Production of Documents and Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/21/2010)

2010-12-21

1

View

NOTICE OF SERVICE of Mylan's Third Set of Requests for Production of Documents and Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/22/2010)

2010-12-22

1

View

SO ORDERED, re 36 MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Melanie R. Rupert, Christine Willgoos, Jason T. Christiansen, Ryan H. Coletti and Evan D. Diamond filed by Supernus Pharmaceuticals Inc., Galderma Laboratories LP, Galderma Laboratories Inc. Signed by Judge Leonard P. Stark on 12/23/2010. (rpg)

2010-12-23

1

No Actions

NOTICE OF SERVICE of Defendants' Objections and Responses to Mylan's First Set of Requests for Production of Documents and Things to Defendants (Nos. 1-15) and Defendants' Objections and Responses to Mylan's First Set of Interrogatories (Nos. 1-7) by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Noreika, Maryellen) (Entered: 01/03/2011)

2011-01-03

1

View

NOTICE OF SERVICE of Mylan's Fourth Set of Document Requests by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 01/05/2011)

2011-01-05

1

View

STIPULATION [JOINT EXPERT DISCOVERY STIPULATION] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)

2011-01-07

1

View

STIPULATION [STIPULATION CONCERNING DISCOVERY IN CONSOLIDATED ACTIONS] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)

2011-01-07

1

View

STIPULATION AND AGREEMENT TO BE BOUND by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)

2011-01-07

1

View

STIPULATION TO AMEND PROTECTIVE ORDER re (38 in 1:09-cv-00184-LPS) Order, by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)

2011-01-07

1

View

NOTICE of Issuance of Subpoenas upon Stephen B. Maebius, Sunit Talapatra and Rong-Kun Chang by Mylan Pharmaceuticals Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Moore, David) (Entered: 01/07/2011)

2011-01-07

1

View

NOTICE of Issuance for Subpoenas upon Robert A. Ashley, Arash Raoufinia, and Nirah Shah by Mylan Pharmaceuticals Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Moore, David) (Entered: 01/07/2011)

2011-01-07

1

View

SO ORDERED, STIPULATION TO AMEND PROTECTIVE ORDER re ( 248 in 1:09-cv-00184-LPS, 44 in 1:10-cv-00892-LPS) Stipulation filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 1/10/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS (rpg) (Entered: 01/10/2011)

2011-01-10

1

View

NOTICE of Issuance of Subpoenas upon Foley & Lardner LLP and Hoffman & Baron by Mylan Pharmaceuticals Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Moore, David) (Entered: 01/10/2011)

2011-01-10

1

View

SO ORDERED, re (43 in 1:10-cv-00892-LPS, 247 in 1:09-cv-00184-LPS) Stipulation STIPULATION AND AGREEMENT TO BE BOUND by Protocol for Electronic Discovery filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 1/10/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg)

2011-01-10

1

No Actions

SO ORDERED, re (42 in 1:10-cv-00892-LPS, 246 in 1:09-cv-00184-LPS) Stipulation regarding discovery filed by Mylan Pharmaceuticals Inc.. Signed by Judge Leonard P. Stark on 1/10/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS (rpg)

2011-01-10

1

No Actions

SO ORDERED, re 41 Stipulation regarding joint expert discovery filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 1/10/2011. (rpg)

2011-01-10

1

No Actions

NOTICE of Issuance of Subpoenas upon Foley & Lardner LLP and Hoffman & Baron by Mylan Pharmaceuticals Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Moore, David) (Entered: 01/13/2011)

2011-01-13

1

View

NOTICE OF SERVICE of Mylan's Response to Defendants' First Set of Interrogatories and Response to Defendants' First Set of Requests for Production of Documents and Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 01/19/2011)

2011-01-19

1

View

NOTICE OF SERVICE of Defendants' Objections and Responses to Mylan's Second Set of Requests for Production of Documents and Things to Defendants (Nos. 16-27) by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/19/2011)

2011-01-19

1

View

NOTICE OF SERVICE of Defendants' Objections and Responses to Mylan's Third Set of Requests for Production of Documents and Things to Defendants (Nos. 28-43) by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/20/2011)

2011-01-20

1

View

NOTICE OF SERVICE of Second Set of Requests for the Production of Documents and Things by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/21/2011)

2011-01-21

1

View

NOTICE OF SERVICE of VARIOUS SUBPOENA OBJECTIONS AND RESPONSES - See Notice for Complete Details by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/24/2011)

2011-01-24

1

View

NOTICE OF SERVICE of Mylan's Fifth Set of Requests for Production of Documents and Things to Defendants by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 01/25/2011)

2011-01-25

1

View

Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding discovery conference. (Moore, David) (Entered: 01/25/2011)

2011-01-25

1

View

NOTICE to Take Deposition of Mylan Pharmaceuticals Inc. on February 16, 2011 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/26/2011)

2011-01-26

1

View

NOTICE to Take Deposition of Jason Harper on February 16, 2011 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/26/2011)

2011-01-26

1

View

NOTICE to Take Deposition of S. Wayne Talton on February 22, 2011 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/26/2011)

2011-01-26

1

View

NOTICE to Take Deposition of John Kirsch on February 23, 2011 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/26/2011)

2011-01-26

1

View

NOTICE to Take Deposition of Ray Higgins on February 24, 2011 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/26/2011)

2011-01-26

1

View

NOTICE to Take Deposition of David Wargo on March 1, 2011 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/26/2011)

2011-01-26

1

View

NOTICE OF SERVICE of Defendants' Supplemental Responses to Mylan's Interrogatory Nos. 1, 2 and 6 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/27/2011)

2011-01-27

1

View

NOTICE to Take Deposition of Supernus Pharmaceuticals, Inc., Galderma Laboratories Inc., and Galderma Laboratories, L.P. on February 14, 2011 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 01/28/2011)

2011-01-28

1

View

Order Setting Teleconference: Discovery Teleconference set for 2/2/2011 03:30 PM before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 1/31/11. (ntl) (Entered: 01/31/2011)

2011-01-31

1

View

NOTICE OF SERVICE of Mylan's Sixth Set of Requests for Production of Documents to Defendants by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 01/31/2011)

2011-01-31

1

View

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding discovery teleconference scheduled for February 2, 2011. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Blumenfeld, Jack) (Entered: 02/01/2011)

2011-02-01

1

View

SEALED Letter to The Honorable Leonard P. Stark from David E. Moore regarding discovery dispute - re 65 Order Setting Teleconference. (Moore, David) (Entered: 02/01/2011)

2011-02-01

1

View

NOTICE to Take Deposition of Supernus Pharmaceuticals, Inc. on February 14, 2011 [30(b)(6)] by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/01/2011)

2011-02-01

1

View

NOTICE to Take Deposition of Galderma Laboratories, Inc. and Galderma Laboratories, L.P. on February 15, 2011 [30(b)(6)] by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/01/2011)

2011-02-01

1

View

SEALED Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding response to Mylan's February 1, 2011 letter - re 68 Letter. (Attachments: # 1 Exhibit 1-4)(Blumenfeld, Jack) (Entered: 02/02/2011)

2011-02-02

1

View

SEALED Letter to The Honorable Leonard P. Stark from David E. Moore regarding response to Jack Blumenfeld's February 1, 2011 letter - re 67 Letter,. (Moore, David) (Entered: 02/02/2011)

2011-02-02

1

View

REDACTED VERSION of 71 Letter by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Blumenfeld, Jack) (Entered: 02/02/2011)

2011-02-02

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Discovery Teleconference held on 2/2/2011. (Court Reporter B. Gaffigan.) (ntl)

2011-02-02

1

No Actions

NOTICE OF SERVICE of Defendants' Objections and Responses to Mylan's Fourth Set of Requests for Production of Documents and Things to Defendants (Nos. 44-47) by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 02/03/2011)

2011-02-03

1

View

NOTICE OF SERVICE of Mylan's Seventh Set of Requests for Production of Documents and Things to Defendants by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/04/2011)

2011-02-04

1

View

NOTICE OF SERVICE of Mylan's Second Supplemental Response to Defendants' Interrogatory No. 2 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/07/2011)

2011-02-07

1

View

NOTICE OF SERVICE of Third Set of Requests for the Production of Documents and Things by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Noreika, Maryellen) (Entered: 02/07/2011)

2011-02-07

1

View

Pro Hac Vice Attorneys Melissa A. Kopacz, Michael A. Berta, Ron E. Shulman, Terry Kearney, Lorelei P Westin, Michael D Nguyen, Tung-On Kong for Mylan Pharmaceuticals Inc. added for electronic noticing. (nms)

2011-02-07

1

No Actions

REDACTED VERSION of 68 Letter to The Honorable Leonard P. Stark from David E. Moore regarding discovery dispute by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-D)(Moore, David) (Entered: 02/08/2011)

2011-02-08

1

View

REDACTED VERSION of 72 Letter to The Honorable Leonard P. Stark from David E. Moore regarding response to Jack Blumenfeld's February 1, 2011 letter by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1-2)(Moore, David) (Entered: 02/09/2011)

2011-02-09

1

View

NOTICE OF SERVICE of Mylan's Objections and Responses to Defendants': Notice of Deposition of Jason Harper, Notice of Deposition of Ray Higgins, Notice of Deposition of John Kirsch, Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6), Notice of Depostion of S. Wayne Talton, and Notice of Deposition of David Wargo by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/10/2011)

2011-02-10

1

View

NOTICE to Take Deposition of Supernus Pharmaceuticals, Inc. on February 28, 2011 (Supplemental Notice) by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/10/2011)

2011-02-10

1

View

NOTICE to Take Deposition of Galerma Laboratories, Inc. and Galderma Laboratories, L.P. on February 28, 2011 (Supplemental Notice) by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/10/2011)

2011-02-10

1

View

NOTICE OF SERVICE of 1) Defendants' Second Set of Interrogatories; and 2) Defendants' Second Supplemental Response to Mylan's Interrogatory No. 2 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Noreika, Maryellen) (Entered: 02/10/2011)

2011-02-10

1

View

NOTICE requesting Clerk to remove Michael A. Berta, formerly of Wilson Sonsini Goodrich & Rosati as co-counsel. Reason for request: no longer with firm. (Moore, David) (Entered: 02/16/2011)

2011-02-16

1

View

NOTICE OF SERVICE of 1) Defendants' Requests for Admission; 2) Defendants' Third Set of Interrogatories; 3) Defendants' Fourth Set of Requests for the Production of Documents and Things; 4) Galderma's Objections and Responses to Mylan's Supplemental Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6); and 5) Supernus's Objections and Responses to Mylan's Supplemental Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 02/16/2011)

2011-02-16

1

View

Official Transcript of Telephone Conference held on February 2, 2011 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 3/9/2011. Redacted Transcript Deadline set for 3/21/2011. Release of Transcript Restriction set for 5/17/2011. (bpg) (Entered: 02/16/2011)

2011-02-16

1

View

NOTICE OF SERVICE of Mylan's First Set of Requests for Admission to Defendants and Mylan's Second Set of Interrogatories (No.8) by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/17/2011)

2011-02-17

1

View

NOTICE OF SERVICE of Mylan's Objections and Supplemental Response to Defendants' Interrogatory No. 1 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/17/2011)

2011-02-17

1

View

NOTICE to Take Deposition of Pabmanabh Bhatt on March 14, 2011 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/21/2011)

2011-02-21

1

View

NOTICE OF SERVICE of Mylan's Response to Defendants' Second Set of Requests for Production of Documents and Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/23/2011)

2011-02-23

1

View

NOTICE OF SERVICE of Defendants' Objections and Responses to Mylan's Fifth Set of Requests for Production of Documents and Things to Defendants (Nos. 48-59) by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 02/24/2011)

2011-02-24

1

View

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding advising the Court that there have been no settlement discussions since the entry of the December 13, 2010 Scheduling Order. (Blumenfeld, Jack) (Entered: 02/25/2011)

2011-02-25

1

View

SEALED CLAIM CONSTRUCTION OPENING BRIEF filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 02/25/2011)

2011-02-25

1

View

SEALED DECLARATION re 93 Claim Construction Opening Brief (DECLARATION OF LORELEI WESTIN IN SUPPORT OF MYLAN'S OPENING CLAIM CONSTRUCTION BRIEF) by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 02/25/2011)

2011-02-25

1

View

CLAIM CONSTRUCTION OPENING BRIEF -- Exhibit 5 to Brief Filed Separately Under Seal -- filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1-12)(Noreika, Maryellen) (Entered: 02/25/2011)

2011-02-25

1

View

SEALED EXHIBIT re 95 Claim Construction Opening Brief -- Exhibit 5 to Defendants' Opening Brief Regarding Claim Construction -- by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 02/25/2011)

2011-02-25

1

View

REDACTED VERSION of 96 Exhibit to a Document -- Exhibit 5 to Defendants' Opening Brief Regarding Claim Construction -- by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 02/25/2011)

2011-02-25

1

View

NOTICE OF SERVICE of Defendants' Objections and Responses to Mylan's Sixth Set of Requests for Production of Documents and Things to Defendants (Nos. 60-67) by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 03/02/2011)

2011-03-02

1

View

REDACTED VERSION of 93 Claim Construction Opening Brief by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 03/04/2011)

2011-03-04

1

View

REDACTED VERSION of 94 Declaration (DECLARATION OF LORELEI WESTIN IN SUPPORT OF MYLAN'S OPENING CLAIM CONSTRUCTION BRIEF) by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1-3, # 2 Exhibit 4-13)(Moore, David) (Entered: 03/04/2011)

2011-03-04

1

View

NOTICE OF SERVICE of Defendants' Objections and Responses to Mylan's Seventh Set of Requests for Production of Documents and Things to Defendants (Nos. 68-82) by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 03/07/2011)

2011-03-07

1

View

NOTICE OF SERVICE of Mylan's Response to Defendants' Third Set of Requests for Production of Documents and Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 03/10/2011)

2011-03-10

1

View

SEALED STIPULATION AND ORDER by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 03/11/2011)

2011-03-11

1

View

CLAIM CONSTRUCTION ANSWERING BRIEF re 95 Claim Construction Opening Brief filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 03/11/2011)

2011-03-11

1

View

CLAIM CONSTRUCTION ANSWERING BRIEF re 93 Claim Construction Opening Brief filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 03/11/2011)

2011-03-11

1

View

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding March 21 Markman hearing. (Blumenfeld, Jack) (Entered: 03/14/2011)

2011-03-14

1

View

Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding Markman hearing - re 106 Letter. (Moore, David) (Entered: 03/15/2011)

2011-03-15

1

View

ORAL ORDER: IT IS ORDERED that each side shall have 30 minutes of argument during the Markman Hearing on 3/21/11. ORDERED by Judge Leonard P. Stark on 3/16/11. (ntl) (Entered: 03/16/2011)

2011-03-16

1

View

SO ORDERED, re 103 {SEALED} Stipulation and Order filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 3/16/11. (ntl)

2011-03-16

1

No Actions

REDACTED VERSION of 103 Stipulation and Order by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 03/18/2011)

2011-03-18

1

View

NOTICE OF SERVICE of 1) Defendants' Objections and Responses to Mylan's First Set of Requests for Admission to Defendants; 2) Defendants' Objections and Responses to Mylan's Second Set of Interrogatories (No. 8); and 3) Defendants' Supplemental Responses to Mylan's Interrogatory Nos. 3 and 4, Defendants' Second Supplemental Responses to Mylan's Interrogatory Nos. 1 and 6, and Defendants' Third Supplemental Response to Mylan's Interrogatory No. 2 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 03/18/2011)

2011-03-18

1

View

NOTICE OF SERVICE of Mylan's Third Supplemental Response to Defendants' Interrogatory No. 2; Mylan's Response to Defendants' Third Set of Interrogatories; Mylan's Response to Defendants' Fourth Set of Requests for Production of Documents and Things; Mylan's Response to Defendants' Requests for Admission; and Production of Documents Cited in Mylan's Third Supplemental Response to Defendants' Interrogatory No. 2 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 03/21/2011)

2011-03-21

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Markman Hearing held on 3/21/2011. (Court Reporter B. Gaffigan.) (ntl)

2011-03-21

1

No Actions

NOTICE OF SERVICE of Mylan's Third Supplemental Response to Defendants' Interrogatory No. 2 (Corrected) by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 03/23/2011)

2011-03-23

1

View

Official Transcript of Claim Construction Hearing held on March 21, 2011 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/14/2011. Redacted Transcript Deadline set for 4/25/2011. Release of Transcript Restriction set for 6/22/2011. (bpg) (Entered: 03/24/2011)

2011-03-24

1

View

OPINION re claim construction. Signed by Judge Leonard P. Stark on 3/24/11. (ntl)

2011-03-24

1

Download

ORDER on claim construction re 114 Opinion. Signed by Judge Leonard P. Stark on 3/24/11. (ntl) (Entered: 03/24/2011)

2011-03-24

1

View

ORAL ORDER: IT IS HEREBY ORDERED that Mylan's motion to dismiss exceptional case claims (D.I. 19 ) is DENIED WITHOUT PREJUDICE to renew after judgment on the merits of the parties' infringement and validity claims. ORDERED by Judge Leonard P. Stark on 3/25/11. (ntl) (Entered: 03/25/2011)

2011-03-25

1

View

NOTICE OF SERVICE of Expert Report of David R. Friend and Expert Report of Werner Rubas, Ph.D. by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 03/28/2011)

2011-03-28

1

View

NOTICE OF SERVICE of Expert Report of Edward M. Rudnic, Ph.D. by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 03/28/2011)

2011-03-28

1

View

NOTICE requesting Clerk to remove Ron E. Shulman, Terry Kearney, Roger J. Chin as co-counsel. Reason for request: no longer with firm. (Moore, David) (Entered: 04/06/2011)

2011-04-06

1

View

NOTICE OF SERVICE of Rebuttal Expert Report of David R. Friend by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 04/18/2011)

2011-04-18

1

View

NOTICE OF SERVICE of 1) Supplemental Expert Report of John P. Murry, Jr., Ph.D.; and 2) Rebuttal Expert Report of Edward M. Rudnic, Ph.D. by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 04/18/2011)

2011-04-18

1

View

MOTION for Pro Hac Vice Appearance of Attorney David S. Steuer and Matthew R. Reed of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 04/19/2011)

2011-04-19

1

View

SO ORDERED, re 122 MOTION for Pro Hac Vice Appearance of Attorney David S. Steuer and Matthew R. Reed of Wilson Sonsini Goodrich & Rosati filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 4/20/11. (ntl)

2011-04-20

1

No Actions

Pro Hac Vice Attorney Matthew R. Reed,David S. Steuer for Mylan Pharmaceuticals Inc. added for electronic noticing. (dmp, )

2011-04-25

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Kirin K. Gill of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 04/26/2011)

2011-04-26

1

View

SO ORDERED, re 123 MOTION for Pro Hac Vice Appearance of Attorney Kirin K. Gill of Wilson Sonsini Goodrich & Rosati filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 4/27/11. (ntl)

2011-04-27

1

No Actions

NOTICE requesting Clerk to remove Melissa A. Kopacz as co-counsel. Reason for request: no longer with firm. (Moore, David) (Entered: 05/04/2011)

2011-05-04

1

View

Pro Hac Vice Attorney Kirin K. Gill for Mylan Pharmaceuticals Inc. added for electronic noticing. (nms)

2011-05-09

1

No Actions

NOTICE OF SERVICE of Mylan's Second Supplemental Response to Defendants' Interrogatory No. 1 and Mylan's Fourth Supplemental Response to Defendants' Interrogatory No. 2 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 05/13/2011)

2011-05-13

1

View

ORAL ORDER: IT IS HEREBY ORDERED that the Pretrial Conference scheduled for 6/15/11 at 10:00 AM is CANCELLED; the Pretrial Conference is hereby rescheduled for 6/13/11 at 3:30 PM. ORDERED by Judge Leonard P. Stark on 5/23/11. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 05/23/2011)

2011-05-23

1

View

STIPULATION Regarding Bifurcation of Exeptional Case Claims by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 05/26/2011)

2011-05-26

1

View

SO ORDERED, re 127 Stipulation and Order re Galderma's exceptional case claims. Signed by Judge Leonard P. Stark on 5/27/11. (ntl)

2011-05-27

1

No Actions

Proposed Pretrial Order by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1-11)(Noreika, Maryellen) (Entered: 06/06/2011)

2011-06-06

1

View

SEALED EXHIBIT re (128 in 1:10-cv-00892-LPS) Proposed Pretrial Order, -- Exhibit 3 to Proposed Joint Pretrial Order -- by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 06/06/2011)

2011-06-06

1

View

MOTION for Pro Hac Vice Appearance of Attorney Joseph M. O'Malley, Jr. and Shenade Walker - filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 06/07/2011)

2011-06-07

1

View

REDACTED VERSION of (258 in 1:09-cv-00184-LPS, 129 in 1:10-cv-00892-LPS) Exhibit to a Document, by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 06/09/2011)

2011-06-09

1

View

SO ORDERED, re 130 MOTION for Pro Hac Vice Appearance of Attorney Joseph M. O'Malley, Jr. and Shenade Walker filed by Supernus Pharmaceuticals Inc., Galderma Laboratories LP, Galderma Laboratories Inc. Signed by Judge Leonard P. Stark on 6/9/11. (ntl)

2011-06-09

1

No Actions

Minute Entry for proceedings held before Judge Leonard P. Stark - Pretrial Conference held on 6/13/2011. (Court Reporter B. Gaffigan.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)

2011-06-13

1

No Actions

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding deposition objections. (Attachments: # 1 Portions of S. Talton Deposition Transcript)(Blumenfeld, Jack) (Entered: 07/03/2011)

2011-07-03

1

View

SO ORDERED, re (257 in 1:09-cv-00184-LPS, 128 in 1:10-cv-00892-LPS) Proposed Joint Pretrial Order. Signed by Judge Leonard P. Stark on 7/5/11. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)

2011-07-05

1

No Actions

Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial held on 7/5/2011. (Court Reporters Gaffigan/Maurer) (ntl)

2011-07-05

1

No Actions

Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial held on 7/6/2011. (Court Reporters Gaffigan, Gunning.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)

2011-07-06

1

No Actions

Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial held on 7/7/2011. (Court Reporter Brian Gaffigan.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg)

2011-07-07

1

No Actions

Official Official Transcript of Pretrial Conference held on June 13, 2011 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 7/29/2011. Redacted Transcript Deadline set for 8/8/2011. Release of Transcript Restriction set for 10/6/2011. (bpg) (Entered: 07/08/2011)

2011-07-08

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Bench Trial completed on 7/8/2011. (Court Reporter B. Gaffigan.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)

2011-07-08

1

No Actions

STATEMENT -- JOINT ERRATA FOR TRIAL TRANSCRIPTS -- by Galderma Laboratories Inc., Galderma Laboratories LP, Mylan Pharmaceuticals Inc., New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 07/20/2011)

2011-07-20

1

View

STATEMENT -- Galderma's Errata for Trial Transcripts -- by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 07/20/2011)

2011-07-20

1

View

POST TRIAL BRIEF [Opening Post-Trial Brief] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/21/2011)

2011-07-21

1

View

Proposed Findings of Fact by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/21/2011)

2011-07-21

1

View

POST TRIAL BRIEF by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 07/21/2011)

2011-07-21

1

View

Proposed Findings of Fact by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 07/21/2011)

2011-07-21

1

View

NOTICE of Firm Name Change by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc. (Blumenfeld, Jack) (Entered: 07/26/2011)

2011-07-26

1

View

Official Transcript of Bench Trial - Volume A held on Tuesday, July 5, 2011 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/17/2011. Redacted Transcript Deadline set for 8/29/2011. Release of Transcript Restriction set for 10/25/2011. (bpg) (Entered: 07/27/2011)

2011-07-27

1

Download

Official Transcript of Bench Trial - Volume B held on Wednesday, July 6, 2011 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/17/2011. Redacted Transcript Deadline set for 8/29/2011. Release of Transcript Restriction set for 10/25/2011. (bpg) (Entered: 07/27/2011)

2011-07-27

1

Download

Official Transcript of Bench Trial - Volume C held on Thursday, July 7, 2011 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/17/2011. Redacted Transcript Deadline set for 8/29/2011. Release of Transcript Restriction set for 10/25/2011. (bpg) (Entered: 07/27/2011)

2011-07-27

1

Download

Official Transcript of Bench Trial - Volume D held on Friday, July 8, 2011 before Judge Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/17/2011. Redacted Transcript Deadline set for 8/29/2011. Release of Transcript Restriction set for 10/25/2011. (bpg) (Entered: 07/27/2011)

2011-07-27

1

Download

POST TRIAL BRIEF Responsive by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Noreika, Maryellen) (Entered: 07/29/2011)

2011-07-29

1

View

POST TRIAL BRIEF Responsive by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 07/29/2011)

2011-07-29

1

View

ORAL ORDER by Judge Leonard P. Stark: IT IS HEREBY ORDERED THAT the parties shall submit on disk, in WordPerfect format, their Proposed Findings of Fact and Conclusions of Law (D.I. 266 ; D.I. 268 ) as well as their Statement of Uncontested Facts (D.I. 257-1), and to do so no later than August 2, 2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg)

2011-08-01

1

No Actions

Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding enclosure of disk - re (137 in 1:10-cv-00892-LPS, 266 in 1:09-cv-00184-LPS) Proposed Findings of Fact, Oral Order,. (Moore, David) (Entered: 08/02/2011)

2011-08-02

1

View

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding enclosing disk of Word Perfect documents. (Blumenfeld, Jack) (Entered: 08/02/2011)

2011-08-02

1

View

POST TRIAL OPINION. Signed by Judge Leonard P. Stark on 9/26/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg) (Entered: 08/26/2011)

2011-08-26

1

View

ORDER directing the parties to submit simultaneous opening briefs ofno more than ten (10) pages on September 2,2011, and answering briefs of no more than five (5) pages on September 7, 2011, addressing the appropriate remedy in view ofthe Court's Opinion. ( Preliminary injunction previously entered will remain in effect until further Order of the Court ). Signed by Judge Leonard P. Stark on 9/26/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg) (Entered: 08/26/2011)

2011-08-26

1

View

POST TRIAL BRIEF SEALED - MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/02/2011)

2011-09-02

1

View

SEALED DECLARATION re (280 in 1:09-cv-00184-LPS, 151 in 1:10-cv-00892-LPS) POST Trial Brief DECLARATION OF PHILIP B. NELSON, PH.D., IN SUPPORT OF MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/02/2011)

2011-09-02

1

View

SEALED DECLARATION re (280 in 1:09-cv-00184-LPS, 151 in 1:10-cv-00892-LPS) POST Trial Brief DECLARATION OF ANTHONY MAURO IN SUPPORT OF MYLAN PHARMACEUTICALS INC.'S OPENING POST-TRIAL BRIEF REGARDING REMEDY by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/02/2011)

2011-09-02

1

View

POST TRIAL BRIEF -- Galderma's Opening Brief Regarding Remedy for Infringement -- by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibits B-C)(Noreika, Maryellen) (Entered: 09/02/2011)

2011-09-02

1

View

SEALED EXHIBIT re 154 POST Trial Brief, -- Exhibits B-C to Galderma's Opening Brief Regarding Remedy for Infringement -- by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 09/02/2011)

2011-09-02

1

View

REDACTED VERSION of (155 in 1:10-cv-00892-LPS) Exhibit to a Document, (284 in 1:09-cv-00184-LPS) Exhibit to a Document, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Mylan Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 09/06/2011)

2011-09-06

1

View

POST TRIAL BRIEF SEALED - Mylan's Responsive Post-Trial Brief Regarding Remedy by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/07/2011)

2011-09-07

1

View

SEALED REPLY BRIEF Regarding Remedy for Infringement filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibits D thruogh H)(Noreika, Maryellen) (Entered: 09/07/2011)

2011-09-07

1

View

SEALED DECLARATION re (158 in 1:10-cv-00892-LPS) Reply Brief of Professor Jerry A. Hausman by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1 and 2)(Noreika, Maryellen) (Entered: 09/07/2011)

2011-09-07

1

View

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding briefing on post-trial remedy issues complete; Galderma is available to present argument on the issues. (Blumenfeld, Jack) (Entered: 09/08/2011)

2011-09-08

1

View

Letter to The Honorable Leonard P. Stark from Richard L. Horwitz, Esquire regarding oral argument on post-trial remedy issues - re (289 in 1:09-cv-00184-LPS, 160 in 1:10-cv-00892-LPS) Letter. (Horwitz, Richard) (Entered: 09/09/2011)

2011-09-09

1

View

REDACTED VERSION of (280 in 1:09-cv-00184-LPS, 151 in 1:10-cv-00892-LPS) POST Trial Brief [MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/09/2011)

2011-09-09

1

View

REDACTED VERSION of (281 in 1:09-cv-00184-LPS, 152 in 1:10-cv-00892-LPS) Declaration, [DECLARATION OF PHILIP B. NELSON, PH.D., IN SUPPORT OF MYLAN'S OPENING POST-TRIAL BRIEF REGARDING REMEDY] by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1)(Moore, David) (Entered: 09/09/2011)

2011-09-09

1

View

REDACTED VERSION of (153 in 1:10-cv-00892-LPS, 282 in 1:09-cv-00184-LPS) Declaration, [DECLARATION OF ANTHONY MAURO IN SUPPORT OF MYLAN PHARMACEUTICALS INC.'S OPENING POST-TRIAL BRIEF REGARDING REMEDY] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/09/2011)

2011-09-09

1

View

NOTICE requesting Clerk to remove Michael D. Nguyen of Wilson Sonsini Goodrich & Rosati as co-counsel. Reason for request: No longer with firm. (Moore, David) (Entered: 09/12/2011)

2011-09-12

1

View

REDACTED VERSION of (158 in 1:10-cv-00892-LPS) Reply Brief, (287 in 1:09-cv-00184-LPS) Reply Brief, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit D-H)(Noreika, Maryellen) (Entered: 09/14/2011)

2011-09-14

1

View

REDACTED VERSION of (159 in 1:10-cv-00892-LPS, 288 in 1:09-cv-00184-LPS) Declaration, by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1 & 2)(Noreika, Maryellen) (Entered: 09/14/2011)

2011-09-14

1

View

REDACTED VERSION of 157 POST Trial Brief (Mylan's Sealed Post-Trial Brief Regarding Remedy) by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 09/14/2011)

2011-09-14

1

View

ORAL ORDER: IT IS HEREBY ORDERED that the Court will hear argument on the post-trial remedies on February 17, 2012 beginning at 3:00 p.m. Each side will be allocated up to one (1) hour to present its argument. ORDERED by Judge Leonard P. Stark on 1/12/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 01/12/2012)

2012-01-12

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Oral Argument held on 2/17/2012. (Court Reporter Valerie Gunning.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)

2012-02-17

1

No Actions

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding bringing the Court's attention to new case law. (Attachments: # 1 Exhibit 1)(Blumenfeld, Jack) (Entered: 03/05/2012)

2012-03-05

1

View

SEALED MOTION UNOPPOSED MOTION TO PARTIALLY SEAL TRANSCRIPT (TRANSCRIPT OF HEARING ON 2/17/12 BEFORE THE HONORABLE LEONARD P. STARK) WITH PROPOSED ORDER - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 03/06/2012)

2012-03-06

1

View

Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding response to plaintiff Galderma's March 5, 2012 letter - re 170 Letter. (Moore, David) (Entered: 03/08/2012)

2012-03-08

1

View

ORDER granting (D.I. 300 in case 1:09-cv-00184-LPS) SEALED UNOPPOSED MOTION TO PARTIALLY SEAL TRANSCRIPT (TRANSCRIPT OF HEARING ON 2/17/12 BEFORE THE HONORABLE LEONARD P. STARK); granting 171 in case 1:10-cv-00892-LPS. Signed by Judge Leonard P. Stark on 3/12/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 03/12/2012)

2012-03-12

1

View

SEALED Transcript of Hearing held on February 17, 2012 before Judge Leonard P. Stark. (Transcript on file in Clerk's Office). (vjg) (Entered: 03/15/2012)

2012-03-15

1

View

{SEALED} MEMORANDUM ORDER re post-trial remedies (See Memorandum Order for further details). Signed by Judge Leonard P. Stark on 5/16/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 05/16/2012)

2012-05-16

1

View

ORAL ORDER: IT IS HEREBY ORDERED as follows: Because the Memorandum Order released on May 16, 2012 (D.I. 175) may contain confidential information, it has been released under seal, pending review by the parties to allow them to submit a single jointly proposed redacted version of the Memorandum Order. Such redacted version shall be submitted no later than May 18, 2012 for review by the Court. The Court will subsequently file a publicly-available version of its Memorandum Order. ORDERED by Judge Leonard P. Stark on 5/16/12. (ntl) (Entered: 05/16/2012)

2012-05-16

1

View

Letter to The Honorable Leonard P. Stark from David E. Moore regarding submission of redacted Memorandum Order - re 175 Memorandum and Order. (Attachments: # 1 Enclosure)(Moore, David) (Entered: 05/18/2012)

2012-05-18

1

View

REDACTED VERSION of 175 Memorandum Order. (ntl) (Entered: 05/25/2012)

2012-05-25

1

View

CASE CLOSED PER D.I. 175, 178 . (ntl)

2012-05-25

1

No Actions

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number 7,749,532 B2. (Attachment: # 1 Memorandum Order)(ntl) (Entered: 05/30/2012)

2012-05-30

1

View

MOTION for Release of Bond Obligation - filed by Galderma Laboratories Inc., Galderma Laboratories LP, New York University, Research Foundation of State University of New York. (Noreika, Maryellen) (Entered: 05/30/2012)

2012-05-30

1

View

PROPOSED ORDER regarding Proposed Judgment by Galderma Laboratories Inc., Galderma Laboratories LP. (Attachments: # 1 Cover Letter to Judge Stark)(Noreika, Maryellen) (Entered: 06/07/2012)

2012-06-07

1

View

JUDGMENT (see document for further details). Signed by Judge Leonard P. Stark on 6/8/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 06/08/2012)

2012-06-08

1

View

RESPONSE to Motion re 180 MOTION for Release of Bond Obligation [MYLAN'S OPPOSITION TO MOTION TO RELEASE BOND] filed by Mylan Pharmaceuticals Inc.. (Horwitz, Richard) (Entered: 06/13/2012)

2012-06-13

1

View

REPLY BRIEF re 180 MOTION for Release of Bond Obligation filed by Galderma Laboratories Inc., Galderma Laboratories LP. (Noreika, Maryellen) (Entered: 06/21/2012)

2012-06-21

1

View

Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding discovery dispute teleconference set for July 10, 2012 at 3:45 p.m.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Noreika, Maryellen) (Entered: 07/02/2012)

2012-07-02

1

View

Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding response to July 2, 2012 letters of Lupin and Amneal - re (62 in 1:11-cv-01106-LPS) Letter, (21 in 1:09-cv-00483-LPS, 29 in 1:10-cv-01112-LPS) Letter. (Noreika, Maryellen) (Entered: 07/03/2012)

2012-07-03

1

View

NOTICE OF APPEAL to the Federal Circuit of 149 Opinion, 182 Judgment, 175 Memorandum and Order . Appeal filed by Mylan Pharmaceuticals Inc.. (Horwitz, Richard) (Entered: 07/09/2012)

2012-07-09

1

View

APPEAL - Credit Card Payment of $ 455.00 received re 187 Notice of Appeal (Federal Circuit) filed by Mylan Pharmaceuticals Inc.. ( Filing fee $ 455, receipt number 0311-1102691.) (Horwitz, Richard)

2012-07-09

1

No Actions

Minute Entry for proceedings held before Judge Leonard P. Stark - Discovery Teleconference held on 7/10/2012. (Court Reporter B. Gaffigan.) Associated Cases: 1:09-cv-00184-LPS, 1:09-cv-00483-LPS, 1:10-cv-00892-LPS, 1:10-cv-01112-LPS, 1:11-cv-01106-LPS(ntl)

2012-07-10

1

No Actions

Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 187 Notice of Appeal (Federal Circuit). (els)

2012-07-11

1

No Actions

Notification regarding 187 Notice of Appeal (Federal Circuit) sent to Reporter Gaffigan (els)

2012-07-11

1

No Actions

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding Court's July 10, 2012 Oral Order. (Blumenfeld, Jack) (Entered: 07/13/2012)

2012-07-13

1

View

NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 187 Notice of Appeal (Federal Circuit) filed by Mylan Pharmaceuticals Inc. USCA Case Number 12-1524 (ntl) (Entered: 07/19/2012)

2012-07-19

1

View

NOTICE OF CROSS APPEAL to the Federal Circuit of 182 Judgment . Cross Appeal filed by Galderma Laboratories Inc., Galderma Laboratories LP. (Blumenfeld, Jack) (Entered: 07/20/2012)

2012-07-20

1

View

TRANSCRIPT REQUEST by Galderma Laboratories Inc., Galderma Laboratories LP TRANSCRIPT NOT NEEDED (Blumenfeld, Jack) (Entered: 07/20/2012)

2012-07-20

1

View

APPEAL - Credit Card Payment of $ 455.00 received re 190 Notice of Cross Appeal filed by Galderma Laboratories LP, Galderma Laboratories Inc.. ( Filing fee $ 455, receipt number 0311-1109749.) (Blumenfeld, Jack)

2012-07-20

1

No Actions

ORAL ORDER re ( 180 in 1:10-cv-00892-LPS, 309 in 1:09-cv-00184-LPS) MOTION for Release of Bond Obligation filed by Research Foundation of State University of New York, Galderma Laboratories LP, New York University, Galderma Laboratories Inc. is DENIED. ORDERED by Judge Leonard P. Stark on 7/24/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 07/24/2012)

2012-07-24

1

View

Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 190 Notice of Cross Appeal. (els)

2012-07-24

1

No Actions

Notification regarding 190 Notice of Cross Appeal sent to Reporter Gaffigan (els)

2012-07-24

1

No Actions

AMENDED ORAL ORDER: Having reviewed the papers submitted (C.A. No. 09-184 D.I. 309, 312, 313; C.A. No. 10-892 D.I. 180, 183, 184), IT IS HEREBY ORDERED that Galderma's Motion to Release Bond (C.A. No. 09-184 D.I. 309; C.A. No. 10-892 D.I. 180) is DENIED. Mylan has filed a Notice of Appeal. (C.A. No. 09-184 D.I. 318; C.A. No. 10-892 D.I. 187) Issues that may be addressed on appeal include issues relating to whether Mylan is entitled to compensation from the bond. Accordingly, the Court sees no just reason to permit Galderma to release the bond at this time. ORDERED by Judge Leonard P. Stark on 7/26/12. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl) (Entered: 07/26/2012)

2012-07-26

1

View

Official Transcript of Telephone Conference held on July 10, 2012 before Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/22/2012. Redacted Transcript Deadline set for 9/4/2012. Release of Transcript Restriction set for 10/30/2012. (bpg) (Entered: 08/01/2012)

2012-08-01

1

View

Amended NOTICE OF APPEAL to the Federal Circuit of 182 Judgment, 175 Memorandum and Order . Appeal filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 08/03/2012)

2012-08-03

1

View

NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 190 Notice of Cross Appeal filed by Galderma Laboratories LP, Galderma Laboratories Inc. USCA Case Number 12-1555. (ntl) (Entered: 08/06/2012)

2012-08-03

1

View

Amended Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 195 Notice of Appeal (Federal Circuit). (els)

2012-08-06

1

No Actions

Notification regarding 195 Amended Notice of Appeal (Federal Circuit) sent to Reporter Gaffigan (els)

2012-08-06

1

No Actions

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding Mylan's December 19, 2012 letter to the FDA. (Attachments: # 1 Exhibit A)(Blumenfeld, Jack) (Entered: 01/07/2013)

2013-01-07

1

View

ORAL ORDER by Judge Leonard P. Stark: Having reviewed the January 7, 2013 letter from Defendant (D.I. 197), IT IS HEREBY ORDERED that Plaintiff shall respond to Defendant's letter no later than January 15, 2013. (rpg) (Entered: 01/11/2013)

2013-01-11

1

View

Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding Response to Galderma's January 7, 2013 Letter Application - re 197 Letter. (Moore, David) (Entered: 01/15/2013)

2013-01-15

1

View

ORAL ORDER: Defendants' letter request for entry of an order directed to the U.S. Food & Drug Administration (D.I. 197; see also D.I. 198, 199) is DENIED. ORDERED by Judge Leonard P. Stark on 1/18/13. (ntl) (Entered: 01/18/2013)

2013-01-18

1

View

MANDATE of USCA as to 195 Notice of Appeal (Federal Circuit) filed by Mylan Pharmaceuticals Inc., 190 Notice of Cross Appeal filed by Galderma Laboratories LP, Galderma Laboratories Inc., 187 Notice of Appeal (Federal Circuit) filed by Mylan Pharmaceuticals Inc. USCA Decision: Affirmed in part, Vacated in part, and Remanded. (ntl) (Entered: 09/13/2013)

2013-09-13

1

View

ORAL ORDER: IT IS HEREBY ORDERED that the parties shall submit a status report on or before 9/30/13. ORDERED by Judge Leonard P. Stark on 9/16/13. Associated Cases: 1:09-cv-00184-LPS et al.(ntl) (Entered: 09/16/2013)

2013-09-16

1

View

Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding status. (Attachments: # 1 Exhibit A)(Noreika, Maryellen) (Entered: 09/30/2013)

2013-09-30

1

View

Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding Joint Status Report. (Noreika, Maryellen) (Entered: 10/30/2013)

2013-10-30

1

View

STANDING ORDER AND NOTICE REGARDING RETURN OF SEALED DOCUMENTS: Pursuant to the attached STANDING ORDER dated January 8, 2013, sealed documents identified on the attached letters will be claimed by the FILING party/attorney no later than 7/16/19. Filing attorney or their designee shall CLAIM their sealed documents by contacting the Clerk's Office at 302-573-6170 or by sending a courier to claim and receipt for the sealed documents. Documents not claimed shall be unsealed and handled pursuant to the standing order. Signed by Judge Gregory M. Sleet on 1/8/13. (rwc) (Entered: 07/02/2019)

2019-07-02

1

View

Letter to David E. Moore, Esq., from Clerk, dated 7/2/19, regarding return of sealed documents ready for pick-up at Clerk's Office. (rwc) (Entered: 07/02/2019)

2019-07-02

1

View

Letter to Jack B. Blumenfeld, Esq., from Clerk, dated 7/2/19, regarding return of sealed documents ready for pick-up at Clerk's Office. (rwc) (Entered: 07/02/2019)

2019-07-02

1

View

ACKNOWLEDGMENT OF RECEIPT of the following sealed documents, signed on behalf of Morris Nichols Arsht & Tunnell : D.I. # 71, 96, 129, 155, 158, 159. (rwc) (Entered: 07/03/2019)

2019-07-03

1

View

ACKNOWLEDGMENT OF RECEIPT of the following sealed documents, signed on behalf of Potter Anderson & Corroon, LLP : D.I. # 68, 72, 93, 94, 103, 151, 152, 153, 157, 171. (rwc) (Entered: 07/03/2019)

2019-07-03

1

View

Overview

Parties

Defendant

Supernus Pharmaceuticals Inc. Follow

Represented By

Mylan Pharmaceuticals Inc. Follow

Represented By

Counter Defendant

Galderma Laboratories Inc. Follow

Represented By

Galderma Laboratories LP Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dlk) (Entered: 10/19/2010)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2; (dlk) (Entered: 10/19/2010)

Summons Issued as to Galderma Laboratories Inc. on 10/19/2010; Galderma Laboratories LP on 10/19/2010; Supernus Pharmaceuticals Inc. on 10/19/2010. (dzs, )

No Summons Issued (dlk)

SUMMONS Returned Executed by Mylan Pharmaceuticals Inc.. Supernus Pharmaceuticals Inc. served on 10/19/2010, answer due 11/9/2010. (Moore, David) (Entered: 10/20/2010)

SUMMONS Returned Executed by Mylan Pharmaceuticals Inc.. Galderma Laboratories Inc. served on 10/19/2010, answer due 11/9/2010. (Moore, David) (Entered: 10/20/2010)

SUMMONS Returned Executed by Mylan Pharmaceuticals Inc.. Galderma Laboratories LP served on 10/19/2010, answer due 11/9/2010. (Moore, David) (Entered: 10/20/2010)

MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter and for Failure to State a Claim - filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Blumenfeld, Jack) (Entered: 10/26/2010)

Disclosure Statement pursuant to Rule 7.1 filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc. identifying Corporate Parent Galderma Pharma S.A. for Galderma Laboratories Inc... (Blumenfeld, Jack) (Entered: 10/26/2010)

Disclosure Statement pursuant to Rule 7.1 filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc. identifying Corporate Parent Galderma General LLC, Corporate Parent Galderma Limited LLC for Galderma Laboratories LP.. (Blumenfeld, Jack) (Entered: 10/26/2010)

Disclosure Statement pursuant to Rule 7.1 filed by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc. identifying Corporate Parent none for Supernus Pharmaceuticals Inc... (Blumenfeld, Jack) (Entered: 10/26/2010)

RESPONSE to Motion re 7 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter and for Failure to State a Claim [PLAINTIFF'S OPPOSITION TO MOTION TO DISMISS] filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Moore, David) (Entered: 10/27/2010)

Case assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (bkb)

AFFIDAVIT of Service for Summons, Complaint and the Notice, Consent and Reference to a Magistrate Judge Forms served on Galderma Laboratories, L.P. on October 19, 2010, filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 11/02/2010)

MOTION for Pro Hac Vice Appearance of Attorney Ron E. Shulman, Terry Kearney, Melissa A. Kopacz, Michael D. Nguyen, Michael A. Berta, Tung-On Kong and Lorelie P. Westin of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 11/08/2010)

NOTICE of Withdrawal of Motion by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc. re 7 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter and for Failure to State a Claim (Blumenfeld, Jack) (Entered: 11/08/2010)

ANSWER to 1 Complaint, for Declaratory Judgment, COUNTERCLAIM against Mylan Pharmaceuticals Inc. by Galderma Laboratories LP, Galderma Laboratories Inc., Supernus Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Noreika, Maryellen) (Entered: 11/09/2010)

Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding scheduling of discovery dispute teleconference. (Moore, David) (Entered: 11/11/2010)

ANSWER to 15 Answer to Complaint, Counterclaim (PLAINTIFF'S ANSWER TO DEFENDANTS' COUNTERCLAIM) by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 11/12/2010)

MOTION to Dismiss Based upon (MOTION TO DISMISS DEFENDANTS' "EXCEPTIONAL CASE" CLAIM PURSUANT TO FED. R. CIV. P. 12(B)(6)) - filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order)(Moore, David) (Entered: 11/12/2010)

Letter to The Honorable Leonard P. Stark from David E. Moore regarding opening discovery dispute - re 17 Order Setting Teleconference,,. (Attachments: # 1 Exhibit A-C)(Moore, David) (Entered: 11/16/2010)

Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 11/19/2010. (Court Reporter B. Gaffigan.) Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(ntl)

Letter to The Honorable Leonard P. Stark from David E. Moore and Jack B. Blumenfeld regarding case scheduling - re Telephone Conference. (Attachments: # 1 Exhibit A-B)(Moore, David) (Entered: 11/23/2010)

NOTICE OF SERVICE of Mylan's First Set of Requests for Production of Documents and Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/03/2010)

NOTICE OF SERVICE of Mylan's First Set of Interrogatories (Nos. 1-7) by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/03/2010)

Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding the Court's December 2, 2010 Order. (Blumenfeld, Jack) (Entered: 12/06/2010)

Letter to The Honorable Leonard P. Stark from Richard L. Horwitz, Esquire regarding response to Galderma's letter dated December 6, 2010 - re (240 in 1:09-cv-00184-LPS, 26 in 1:10-cv-00892-LPS) Letter. (Horwitz, Richard) (Entered: 12/06/2010)

NOTICE OF SERVICE of Mylan's Initial Disclosure by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/06/2010)

Letter to The Honorable Leonard P. Stark from David E. Moore regarding Scheduling Order (on behalf of all parties). (Attachments: # 1 Exhibit A-B)(Moore, David) (Entered: 12/08/2010)

PROPOSED ORDER Proposed Scheduling Order (on behalf of all parties) re 30 Letter by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 12/08/2010)

NOTICE OF SERVICE of Defendants' Rule 26(a)(1) Initial Disclosures by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 12/13/2010)

REPLY BRIEF re 19 MOTION to Dismiss Based upon (MOTION TO DISMISS DEFENDANTS' "EXCEPTIONAL CASE" CLAIM PURSUANT TO FED. R. CIV. P. 12(B)(6)) filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 12/13/2010)

NOTICE OF SERVICE of 1) Defendants' First Set of Interrogatories; and 2) Defendants' First Set of Requests for the Production of Documents and Things by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 12/16/2010)

NOTICE OF SERVICE of Mylan's Second Set of Requests for Production of Documents and Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/21/2010)

NOTICE OF SERVICE of Mylan's Third Set of Requests for Production of Documents and Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/22/2010)

NOTICE OF SERVICE of Mylan's Fourth Set of Document Requests by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 01/05/2011)

STIPULATION [JOINT EXPERT DISCOVERY STIPULATION] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)

STIPULATION [STIPULATION CONCERNING DISCOVERY IN CONSOLIDATED ACTIONS] by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)

STIPULATION AND AGREEMENT TO BE BOUND by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)

STIPULATION TO AMEND PROTECTIVE ORDER re (38 in 1:09-cv-00184-LPS) Order, by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/07/2011)

NOTICE of Issuance of Subpoenas upon Stephen B. Maebius, Sunit Talapatra and Rong-Kun Chang by Mylan Pharmaceuticals Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Moore, David) (Entered: 01/07/2011)

NOTICE of Issuance for Subpoenas upon Robert A. Ashley, Arash Raoufinia, and Nirah Shah by Mylan Pharmaceuticals Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Moore, David) (Entered: 01/07/2011)

SO ORDERED, STIPULATION TO AMEND PROTECTIVE ORDER re ( 248 in 1:09-cv-00184-LPS, 44 in 1:10-cv-00892-LPS) Stipulation filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 1/10/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS (rpg) (Entered: 01/10/2011)

NOTICE of Issuance of Subpoenas upon Foley & Lardner LLP and Hoffman & Baron by Mylan Pharmaceuticals Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Moore, David) (Entered: 01/10/2011)

SO ORDERED, re (43 in 1:10-cv-00892-LPS, 247 in 1:09-cv-00184-LPS) Stipulation STIPULATION AND AGREEMENT TO BE BOUND by Protocol for Electronic Discovery filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 1/10/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS(rpg)

SO ORDERED, re (42 in 1:10-cv-00892-LPS, 246 in 1:09-cv-00184-LPS) Stipulation regarding discovery filed by Mylan Pharmaceuticals Inc.. Signed by Judge Leonard P. Stark on 1/10/2011. Associated Cases: 1:09-cv-00184-LPS, 1:10-cv-00892-LPS (rpg)

SO ORDERED, re 41 Stipulation regarding joint expert discovery filed by Mylan Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 1/10/2011. (rpg)

NOTICE of Issuance of Subpoenas upon Foley & Lardner LLP and Hoffman & Baron by Mylan Pharmaceuticals Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Moore, David) (Entered: 01/13/2011)

NOTICE OF SERVICE of Mylan's Response to Defendants' First Set of Interrogatories and Response to Defendants' First Set of Requests for Production of Documents and Things by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 01/19/2011)

NOTICE OF SERVICE of Defendants' Objections and Responses to Mylan's Second Set of Requests for Production of Documents and Things to Defendants (Nos. 16-27) by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/19/2011)

NOTICE OF SERVICE of Defendants' Objections and Responses to Mylan's Third Set of Requests for Production of Documents and Things to Defendants (Nos. 28-43) by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/20/2011)

NOTICE OF SERVICE of Second Set of Requests for the Production of Documents and Things by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/21/2011)

NOTICE OF SERVICE of VARIOUS SUBPOENA OBJECTIONS AND RESPONSES - See Notice for Complete Details by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/24/2011)

NOTICE OF SERVICE of Mylan's Fifth Set of Requests for Production of Documents and Things to Defendants by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 01/25/2011)

Letter to The Honorable Leonard P. Stark from David E. Moore, Esquire regarding discovery conference. (Moore, David) (Entered: 01/25/2011)

NOTICE to Take Deposition of Mylan Pharmaceuticals Inc. on February 16, 2011 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/26/2011)

NOTICE to Take Deposition of Jason Harper on February 16, 2011 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/26/2011)

NOTICE to Take Deposition of S. Wayne Talton on February 22, 2011 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/26/2011)

NOTICE to Take Deposition of John Kirsch on February 23, 2011 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/26/2011)

NOTICE to Take Deposition of Ray Higgins on February 24, 2011 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/26/2011)

NOTICE to Take Deposition of David Wargo on March 1, 2011 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/26/2011)

NOTICE OF SERVICE of Defendants' Supplemental Responses to Mylan's Interrogatory Nos. 1, 2 and 6 by Galderma Laboratories Inc., Galderma Laboratories LP, Supernus Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 01/27/2011)

NOTICE to Take Deposition of Supernus Pharmaceuticals, Inc., Galderma Laboratories Inc., and Galderma Laboratories, L.P. on February 14, 2011 by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 01/28/2011)

Order Setting Teleconference: Discovery Teleconference set for 2/2/2011 03:30 PM before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 1/31/11. (ntl) (Entered: 01/31/2011)

Supernus Pharmaceuticals Inc.

Mylan Pharmaceuticals Inc.

Galderma Laboratories Inc.

Galderma Laboratories LP